1c:I[5025,["2266","static/chunks/870fdd6f-6bc796c30d2d789b.js","6874","static/chunks/6874-1092c3b716d98184.js","3063","static/chunks/3063-d60ec0b08e19cd33.js","7698","static/chunks/7698-29ba5779557874ff.js","5801","static/chunks/app/podcast/%5BpodcastSlug%5D/%5BpodcastShortId%5D/%5BepisodeSlug%5D/%5BepisodeShortId%5D/page-b8b82ab127fe442b.js"],"default"] 1d:I[5163,["2266","static/chunks/870fdd6f-6bc796c30d2d789b.js","6874","static/chunks/6874-1092c3b716d98184.js","3063","static/chunks/3063-d60ec0b08e19cd33.js","7698","static/chunks/7698-29ba5779557874ff.js","5801","static/chunks/app/podcast/%5BpodcastSlug%5D/%5BpodcastShortId%5D/%5BepisodeSlug%5D/%5BepisodeShortId%5D/page-b8b82ab127fe442b.js"],"default"] 1e:T4f5,

Antivirals are an important measure to prevent severe disease in vulnerable people with COVID-19.

But there have been concerns antivirals could lead to rebound infections — the resurgence of viral load following the completion of the medication. So what do the latest studies say?

Also, we speak to an expert informing the parliamentary inquiry into long COVID about how to best care for patients.

Guest:

Professor Tania Sorrell

University of Sydney

References:

1f:T52a,[{"@context":"https://schema.org","@type":"Breadc

‌

Episode description

Do antivirals increase your risk of rebound COVID?

Episode description